[PDF][PDF] IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid …
P Paschka, RF Schlenk, VI Gaidzik, M Habdank… - J Clin Oncol, 2010 - academia.edu
J Clin Oncol, 2010•academia.edu
IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and
Confer Adverse Prognosis in Cytogenetical Page 1 IDH1 and IDH2 Mutations Are Frequent
Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in
Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal
Tandem Duplication Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik, Marianne Habdank,
Jan Krönke, Lars Bullinger, Daniela Späth, Sabine Kayser, Manuela Zucknick, Katharina Götze …
Confer Adverse Prognosis in Cytogenetical Page 1 IDH1 and IDH2 Mutations Are Frequent
Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in
Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal
Tandem Duplication Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik, Marianne Habdank,
Jan Krönke, Lars Bullinger, Daniela Späth, Sabine Kayser, Manuela Zucknick, Katharina Götze …
Purpose
To analyze the frequency and prognostic impact of isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) mutations in acute myeloid leukemia (AML).
academia.edu